カナダ - 英語 - Health Canada

eli lilly canada inc - cephalothin sodium - powder for solution - 2g - cephalothin sodium 2g - first generation cephalosporins

カナダ - 英語 - Health Canada

eli lilly canada inc - cephalothin (cephalothin sodium) - liquid - 1g - cephalothin (cephalothin sodium) 1g - first generation cephalosporins

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - cephalexin - powder for suspension - 125 mg/5 ml

サウジアラビア - 英語 - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

eli lilly and company - cephalothin sodium - powder for injection - 2 g

南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - injection - see ingredients - each vial contains cephalothin sodium 1,087 g

インド - 英語 - Central Drugs Standard Control Organization

cadex lab - amikacin - inj - 100/250;mg - 2/2;ml

インド - 英語 - Central Drugs Standard Control Organization

cadex lab - amikacin - inj - 500mg - 2ml

カナダ - 英語 - Health Canada

amgen canada inc - evolocumab - solution - 140mg - evolocumab 140mg - proprotein convertase subtilisin kexin type 9 (pcsk9) inhibitors

カナダ - 英語 - Health Canada

amgen canada inc - evolocumab - solution - 120mg - evolocumab 120mg - proprotein convertase subtilisin kexin type 9 (pcsk9) inhibitors

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogenic kidney [see clinical studies (14.1)], heart [see clinical studies (14.2)] or liver transplants [see clinical studies (14.3)] , in combination with other immunosuppressants. allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (mmf), mycophenolic acid (mpa) or any component of the drug product. mycophenolate mofetil is contraindicated in patients who are allergic to polysorbate 80 (tween). pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mycophenolate during pregnancy and those becoming pregnant within 6 weeks of discontinuing mycophenolate mofetil treatment. to report a pregnancy or obtain information about the registry, visit www.mycophenolaterems.com or call 1-800-617